Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 153

1.

Establishment of occupation chronicles in Grotte Mandrin using sooted concretions: Rethinking the Middle to Upper Paleolithic transition.

Vandevelde S, Brochier JÉ, Petit C, Slimak L.

J Hum Evol. 2017 Nov;112:70-78. doi: 10.1016/j.jhevol.2017.07.016. Epub 2017 Oct 3.

PMID:
29037417
2.

Study of selenium distribution in the protein fractions of the Brazil nut, Bertholletia excelsa.

Chunhieng T, Pétritis K, Elfakir C, Brochier J, Goli T, Montet D.

J Agric Food Chem. 2004 Jun 30;52(13):4318-22.

PMID:
15212486
3.

Immunological markers predicting outcome in patients with hepatitis C treated with interferon-alpha and ribavirin.

Lee S, Macquillan GC, Keane NM, Flexman J, Jeffrey GP, French MA, Brochier J, Price P.

Immunol Cell Biol. 2002 Aug;80(4):391-7.

PMID:
12121229
5.

Growth and immortalization of human myeloma cells in immunodeficient severe combined immunodeficiency mice: a preclinical model.

Rème T, Gueydon E, Jacquet C, Klein B, Brochier J.

Br J Haematol. 2001 Aug;114(2):406-13.

PMID:
11529865
6.
7.

Insulin-like growth factor induces the survival and proliferation of myeloma cells through an interleukin-6-independent transduction pathway.

Ferlin M, Noraz N, Hertogh C, Brochier J, Taylor N, Klein B.

Br J Haematol. 2000 Nov;111(2):626-34.

PMID:
11122111
8.

The Mi15 monoclonal antibody (anti-syndecan-1) is a reliable marker for quantifying plasma cells in paraffin-embedded bone marrow biopsy specimens.

Costes V, Magen V, Legouffe E, Durand L, Baldet P, Rossi JF, Klein B, Brochier J.

Hum Pathol. 1999 Dec;30(12):1405-11.

PMID:
10667416
9.

Interleukin-6 receptor signaling. II. Bio-availability of interleukin-6 in serum.

Gaillard J, Pugnière M, Tresca J, Mani J, Klein B, Brochier J.

Eur Cytokine Netw. 1999 Sep;10(3):337-44.

10.

Activation molecules on human myeloma cells.

Klein B, Li XY, Lu ZY, Jourdan M, Tarte K, Brochier J, Claret E, Wijdenes J, Rossi JF.

Curr Top Microbiol Immunol. 1999;246:335-41. Review. No abstract available.

PMID:
10396073
11.

Tumor necrosis factor is a survival and proliferation factor for human myeloma cells.

Jourdan M, Tarte K, Legouffe E, Brochier J, Rossi JF, Klein B.

Eur Cytokine Netw. 1999 Mar;10(1):65-70.

12.

Interleukin-6 receptor signaling. I. gp80 and gp130 receptor interaction in the absence of interleukin-6.

Gaillard JP, Mani JC, Liautard J, Klein B, Brochier J.

Eur Cytokine Netw. 1999 Mar;10(1):43-8.

13.

Functional interaction of the gp80 and gp130 IL-6 receptors in human B cell malignancies.

Tupitsyn N, Kadagidze Z, Gaillard JP, Sholokhova E, Andreeva L, Liautard J, Duperray C, Klein B, Brochier J.

Clin Lab Haematol. 1998 Dec;20(6):345-52.

PMID:
9951579
14.

Dimerization and activation of the common transducing chain (gp130) of the cytokines of the IL-6 family by mAb.

Autissier P, De Vos J, Liautard J, Tupitsyn N, Jacquet C, Chavdia N, Klein B, Brochier J, Gaillard JP.

Int Immunol. 1998 Dec;10(12):1881-9.

PMID:
9885909
15.

IFN-alpha is a survival factor for human myeloma cells and reduces dexamethasone-induced apoptosis.

Ferlin-Bezombes M, Jourdan M, Liautard J, Brochier J, Rossi JF, Klein B.

J Immunol. 1998 Sep 15;161(6):2692-9.

16.

A gp130 interleukin-6 transducer-dependent SCID model of human multiple myeloma.

Rebouissou C, Wijdenes J, Autissier P, Tarte K, Costes V, Liautard J, Rossi JF, Brochier J, Klein B.

Blood. 1998 Jun 15;91(12):4727-37.

PMID:
9616171
17.

The myeloma cell antigen syndecan-1 is lost by apoptotic myeloma cells.

Jourdan M, Ferlin M, Legouffe E, Horvathova M, Liautard J, Rossi JF, Wijdenes J, Brochier J, Klein B.

Br J Haematol. 1998 Mar;100(4):637-46.

PMID:
9531328
18.
19.

Expression of the interleukin 6 receptor in primary renal cell carcinoma.

Costes V, Liautard J, Picot MC, Robert M, Lequeux N, Brochier J, Baldet P, Rossi JF.

J Clin Pathol. 1997 Oct;50(10):835-40.

20.

Large scale and clinical grade purification of syndecan-1+ malignant plasma cells.

Sun RX, Lu ZY, Wijdenes J, Brochier J, Hertog C, Rossi JF, Klein B.

J Immunol Methods. 1997 Jun 23;205(1):73-9.

PMID:
9236917
21.

Specific inhibition of IL-6 signalling with monoclonal antibodies against the gp130 receptor.

Liautard J, Sun RX, Cotte N, Gaillard JP, Mani JC, Klein B, Brochier J.

Cytokine. 1997 Apr;9(4):233-41.

PMID:
9112331
22.

Activation of the gp130 signaling pathway by monoclonal antibodies directed against the gp130 molecule.

Autissier P, Liautard J, Brochier J, Gaillard JP.

Eur J Immunol. 1997 Mar;27(3):794-7.

PMID:
9079824
24.

Identification of a novel antigenic structure of the human receptor for interleukin-6 involved in the interaction with the glycoprotein 130 chain.

Gaillard JP, Liautard J, Mani JC, Fernandez Suarez JM, Klein B, Brochier J.

Immunology. 1996 Sep;89(1):135-41.

25.

Participation of two Ser-Ser-Phe-Tyr repeats in interleukin-6 (IL-6)-binding sites of the human IL-6 receptor.

Kalai M, Montero-Julian FA, Grötzinger J, Wollmer A, Morelle D, Brochier J, Rose-John S, Heinrich PC, Brailly H, Content J.

Eur J Biochem. 1996 Jun 15;238(3):714-23.

26.

IgA isotype rheumatoid factor in rheumatoid arthritis: clinical implications.

Jorgensen C, Legouffe MC, Bologna C, Brochier J, Sany J.

Clin Exp Rheumatol. 1996 May-Jun;14(3):301-4.

PMID:
8809445
27.

A monoclonal antibody directed against a granule membrane glycoprotein (GMP-140/PADGEM, P-selectin, CD62P) inhibits ristocetin-induced platelet aggregation.

Boukerche H, Ruchaud-Sparagano MH, Rouen C, Brochier J, Kaplan C, McGregor JL.

Br J Haematol. 1996 Feb;92(2):442-51.

PMID:
8603015
28.

In vivo migration of tonsil lymphocytes in rheumatoid synovial tissue engrafted in SCID mice: involvement of LFA-1.

Jorgensen C, Couret I, Canovas F, Bologna C, Brochier J, Reme T, Sany J.

Autoimmunity. 1996;24(3):179-85.

PMID:
9020410
29.

In vivo migration of radiolabelled lymphocytes in rheumatoid synovial tissue engrafted in SCID mice: implication of beta 2 and beta 7-integrin.

Jorgensen C, Couret I, Hellier I, Bologna C, Canovas F, Brochier J, Reme T, Sany J.

J Rheumatol. 1996 Jan;23(1):32-5.

PMID:
8838505
30.

Detection of membrane and soluble interleukin-6 receptor in lymphoid malignancies.

Lavabre-Bertrand T, Exbrayat C, Liautard J, Gaillard JP, Baskevitch PP, Poujol N, Duperray C, Bourquard P, Brochier J.

Br J Haematol. 1995 Dec;91(4):871-7.

PMID:
8547132
31.

Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma.

Bataille R, Barlogie B, Lu ZY, Rossi JF, Lavabre-Bertrand T, Beck T, Wijdenes J, Brochier J, Klein B.

Blood. 1995 Jul 15;86(2):685-91.

PMID:
7605999
32.

Immunomodulating IL-6 activity by murine monoclonal antibodies.

Brochier J, Legouffe E, Liautard J, Gaillard JP, Mao LQ, Bataille R, Rossi JF, Klein B.

Int J Immunopharmacol. 1995 Jan;17(1):41-8.

PMID:
7782152
33.

Preferential use of the VHIII immunoglobulin gene family for the synthesis of rheumatoid factors.

Abderrazik M, Moynier M, Brochier J.

Adv Exp Med Biol. 1995;371B:1207-12. No abstract available.

PMID:
7502785
34.

Human anti-mouse antibody response to the injection of murine monoclonal antibodies against IL-6.

Legouffe E, Liautard J, Gaillard JP, Rossi JF, Wijdenes J, Bataille R, Klein B, Brochier J.

Clin Exp Immunol. 1994 Nov;98(2):323-9.

35.
36.

Administration of an anti-interleukin-6 monoclonal antibody to patients with acquired immunodeficiency syndrome and lymphoma: effect on lymphoma growth and on B clinical symptoms.

Emilie D, Wijdenes J, Gisselbrecht C, Jarrousse B, Billaud E, Blay JY, Gabarre J, Gaillard JP, Brochier J, Raphael M.

Blood. 1994 Oct 15;84(8):2472-9.

PMID:
7919367
37.

Epitope analysis of human IL-6 receptor gp80 molecule with monoclonal antibodies.

Liautard J, Gaillard JP, Mani JC, Montero-Julian F, Duperray C, Lu ZY, Jourdan M, Klein B, Brailly H, Brochier J.

Eur Cytokine Netw. 1994 May-Jun;5(3):293-300.

PMID:
7524715
38.

Quantification of CD24 and CD45 antigens in parallel allows a precise determination of B-cell maturation stages: relevance for the study of B-cell neoplasias.

Lavabre-Bertrand T, Duperray C, Brunet C, Poncelet P, Exbrayat C, Bourquard P, Lavabre-Bertrand C, Brochier J, Navarro M, Janossy G.

Leukemia. 1994 Mar;8(3):402-8.

PMID:
8127145
39.

Immunoassay for functional human soluble interleukin-6 receptor in plasma based on ligand/receptor interactions.

Montero-Julian FA, Liautard J, Flavetta S, Romagné F, Gaillard JP, Brochier J, Klein B, Brailly H.

J Immunol Methods. 1994 Feb 28;169(1):111-21.

PMID:
8133069
41.

CD5 B lymphocyte antigen in monoclonal gammopathy.

Bataille R, Duperray C, Zhang XG, Brochier J, Klein B.

Am J Hematol. 1992 Oct;41(2):102-6.

PMID:
1384312
42.

Major immunoglobulin capping deficiency in the peripheral blood B cells of patients with Sjögren's syndrome.

Bataille R, Zhang XG, Duperray C, Rajzbaum G, Brochier J, Klein B.

Immunology. 1992 Mar;75(3):550-2.

43.

Analysis of monoclonal rheumatoid factors obtained from the B-cell repertoire in rheumatoid arthritis.

Abderrazik M, Moynier M, Jefferis R, Mageed RA, Combe B, Sany J, Brochier J.

Scand J Immunol. 1992 Feb;35(2):149-57.

PMID:
1310812
44.

The B cell repertoire in rheumatoid arthritis. III. Preferential homing of rheumatoid factor-producing B cell precursors in the synovial fluid.

Moynier M, Abderrazik M, Didry C, Sany J, Brochier J.

Arthritis Rheum. 1992 Jan;35(1):49-54.

PMID:
1310022
45.

Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia.

Klein B, Wijdenes J, Zhang XG, Jourdan M, Boiron JM, Brochier J, Liautard J, Merlin M, Clement C, Morel-Fournier B, et al.

Blood. 1991 Sep 1;78(5):1198-204.

PMID:
1715218
46.

The B cell repertoire in rheumatoid arthritis. II. Analysis of rheumatoid factors bearing the IdRQ cross-reactive idiotype.

Abderrazik M, Moynier M, Combe B, Sany J, Brochier J.

Clin Exp Rheumatol. 1991 Sep-Oct;9(5):469-73.

PMID:
1659507
47.

The B cell repertoire in rheumatoid arthritis. I. Frequency of EBV-inducible circulating precursors producing autoantibodies.

Moynier M, Abderrazik M, Rucheton M, Combe B, Sany J, Brochier J.

J Autoimmun. 1991 Aug;4(4):631-49.

PMID:
1663752
48.

The CD24 antigen discriminates between pre-B and B cells in human bone marrow.

Duperray C, Boiron JM, Boucheix C, Cantaloube JF, Lavabre-Bertrand T, Attal M, Brochier J, Maraninchi D, Bataille R, Klein B.

J Immunol. 1990 Dec 1;145(11):3678-83.

PMID:
1700990
49.

Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma.

Klein B, Zhang XG, Jourdan M, Boiron JM, Portier M, Lu ZY, Wijdenes J, Brochier J, Bataille R.

Eur Cytokine Netw. 1990 Oct-Nov;1(4):193-201. Review.

PMID:
2104241
50.

Anti-F(ab')2 antibody response to the injection of anticlass II HLA alloantibodies in patients with rheumatoid arthritis.

Abderrazik M, Moynier M, Eliaou JF, Levy-Biau D, Combe B, Sany J, Clot J, Brochier J.

J Rheumatol. 1990 Jun;17(6):758-63.

PMID:
1696992

Supplemental Content

Loading ...
Support Center